Baltimore, MD · Founded 2012 · Privately Held (backing)
Developer of stem cell therapies designed for treating syndrome and Alzheimer's diseases through regenerative and rejuvenating medicines. Elixirgen Therapeutics is based in Baltimore, MD and was founded in 2012. Its last reported valuation was $67 million in Nov 2023. It has raised $29.1 million across 8 recorded rounds; the latest was a $4 million seed round in Oct 2025.
Last reported valuation
$67.0M
Nov 2026
Priced at
—
Total raised
$29.1M
Last round
Seed Round
Oct 2025
Cap table — not yet on record
Elixirgen Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Frequently asked about Elixirgen Therapeutics
Where does Elixirgen Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Elixirgen Therapeutics's 8 recorded funding rounds.